Literature DB >> 33766974

Severe urticarial rash as the initial symptom of COVID-19 infection.

Sandeep Pagali1, Riddhi S Parikh2.   

Abstract

A 54-year-old woman presented with pruritic rash and hives of 3 days' duration followed by shortness of breath for 1 day. SARS-CoV-2 PCR test for COVID-19 was positive. Cutaneous manifestations of COVID-19 include acral lesions, urticarial rash, erythematous maculopapular rash, vascular rashes and vesicular rash. The cutaneous manifestations are mostly described as self-limiting. Urticarial rashes are not reported as the initial presentation symptom of COVID-19 infection but mostly noted to occur at the same time or after the onset of non-cutaneous symptoms. Management of cutaneous manifestations of COVID-19 affecting quality of life has not been well studied. Antihistamine therapy is the primary recommended therapy. Role of antiviral therapy for severe cases of rash needs to be further assessed. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; dermatology

Mesh:

Substances:

Year:  2021        PMID: 33766974     DOI: 10.1136/bcr-2021-241793

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  Cutaneous Manifestations of SARS-CoV-2 Infection.

Authors:  Thy Huynh; Xavier Sanchez-Flores; Judy Yau; Jennifer T Huang
Journal:  Am J Clin Dermatol       Date:  2022-03-05       Impact factor: 6.233

Review 2.  The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.

Authors:  Gehan A Pendlebury; Peter Oro; William Haynes; Drew Merideth; Samantha Bartling; Michelle A Bongiorno
Journal:  Dermatopathology (Basel)       Date:  2022-06-29

Review 3.  Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management.

Authors:  Waniyah Masood; Shahzaib Ahmad; Noor Ayman Khan; Amaima Shakir; Ghasem Rahmatpour Rokni; Michael H Gold; Clay J Cockerell; Robert A Schwartz; Mohamad Goldust
Journal:  Viruses       Date:  2022-09-06       Impact factor: 5.818

4.  Bioinformatic analyses suggest augmented interleukin-17 signaling as the mechanism of COVID-19-associated herpes zoster.

Authors:  Xin Yu; Linfeng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Environ Sci Pollut Res Int       Date:  2021-07-28       Impact factor: 4.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.